Effect of certolizumab pegol on dermatologic outcomes over 96 weeks in patients with psoriatic arthritis

Author(s):
Mease, P.; Hoepken, B.; Davies, O.; Arledge, T.; Peterson, L.; Heijde, D. van der
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-05-31
Language
English
Is part of
Journal of The American Academy of Dermatology (2015), Vol. 72, no. 5, p. AB232-AB232
hdl
1887/101604